0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Functional Service Provider (FSP) Clinical Research Organization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-21T7736
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Functional Service Provider FSP Clinical Research Organization Market Insights Forecast to 2028
BUY CHAPTERS

Functional Service Provider (FSP) Clinical Research Organization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-21T7736
Report
October 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Functional Service Provider (FSP) Clinical Research Organization - Market Size

The global market for Functional Service Provider (FSP) Clinical Research Organization was estimated to be worth US$ 14240 million in 2023 and is forecast to a readjusted size of US$ 23590 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030

Functional Service Provider (FSP) Clinical Research Organization - Market

Functional Service Provider (FSP) Clinical Research Organization - Market

A Functional Service Provider (FSP) is a personnel sourcing model in which a clinical research organization (CRO) provides staff to biotechnology and pharmaceutical companies in order to perform specific tasks —in a dedicated manner— on a contract basis and under the procedures of the sponsor
The Clinical Research Organization (CRO) market is primarily driven by the increasing demand for efficient and specialized services in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies. CROs offer expertise in study design, patient recruitment, data management, regulatory compliance, and other essential aspects of clinical research. The growing complexity of drug development, coupled with the need for cost-effective and timely trials, contributes to market growth. Moreover, the demonstrated benefits of CROs in accelerating drug development timelines, reducing operational risks, and providing access to diverse patient populations further propel adoption. However, challenges include ensuring data security, addressing potential conflicts of interest, and maintaining transparency in study conduct. Navigating regulatory requirements, building strong collaborations with sponsors, and adhering to ethical standards are ongoing concerns. The market's success relies on continuous innovation in trial methodologies, collaborations between CROs and life sciences companies, and comprehensive education on the benefits and potential challenges of using CRO services while addressing the evolving challenges associated with clinical trial efficiency, patient safety, and research integrity.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Functional Service Provider (FSP) Clinical Research Organization, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Functional Service Provider (FSP) Clinical Research Organization by region & country, by Type, and by Application.
The Functional Service Provider (FSP) Clinical Research Organization market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Service Provider (FSP) Clinical Research Organization.
Market Segmentation

Scope of Functional Service Provider (FSP) Clinical Research Organization - Market Report

Report Metric Details
Report Name Functional Service Provider (FSP) Clinical Research Organization - Market
Forecasted market size in 2030 US$ 23590 million
CAGR 7.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Preclinical CRO
  • Clinical CRO
Segment by Application
  • Small Medium Enterprise
  • Large Enterprise
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IQVIA, Labcorp, Syneos Health, PPD, ICON, PRA, Parexel, Medpace, Wuxi Apptec, EPS International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Functional Service Provider (FSP) Clinical Research Organization manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Functional Service Provider (FSP) Clinical Research Organization in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Functional Service Provider (FSP) Clinical Research Organization in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Functional Service Provider (FSP) Clinical Research Organization - Market size in 2030?

Ans: The Functional Service Provider (FSP) Clinical Research Organization - Market size in 2030 will be US$ 23590 million.

Who are the main players in the Functional Service Provider (FSP) Clinical Research Organization - Market report?

Ans: The main players in the Functional Service Provider (FSP) Clinical Research Organization - Market are IQVIA, Labcorp, Syneos Health, PPD, ICON, PRA, Parexel, Medpace, Wuxi Apptec, EPS International

What are the Application segmentation covered in the Functional Service Provider (FSP) Clinical Research Organization - Market report?

Ans: The Applications covered in the Functional Service Provider (FSP) Clinical Research Organization - Market report are Small Medium Enterprise, Large Enterprise

What are the Type segmentation covered in the Functional Service Provider (FSP) Clinical Research Organization - Market report?

Ans: The Types covered in the Functional Service Provider (FSP) Clinical Research Organization - Market report are Preclinical CRO, Clinical CRO

1 Market Overview
1.1 Functional Service Provider (FSP) Clinical Research Organization Product Introduction
1.2 Global Functional Service Provider (FSP) Clinical Research Organization Market Size Forecast
1.3 Functional Service Provider (FSP) Clinical Research Organization Market Trends & Drivers
1.3.1 Functional Service Provider (FSP) Clinical Research Organization Industry Trends
1.3.2 Functional Service Provider (FSP) Clinical Research Organization Market Drivers & Opportunity
1.3.3 Functional Service Provider (FSP) Clinical Research Organization Market Challenges
1.3.4 Functional Service Provider (FSP) Clinical Research Organization Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Functional Service Provider (FSP) Clinical Research Organization Players Revenue Ranking (2023)
2.2 Global Functional Service Provider (FSP) Clinical Research Organization Revenue by Company (2019-2024)
2.3 Key Companies Functional Service Provider (FSP) Clinical Research Organization Manufacturing Base Distribution and Headquarters
2.4 Key Companies Functional Service Provider (FSP) Clinical Research Organization Product Offered
2.5 Key Companies Time to Begin Mass Production of Functional Service Provider (FSP) Clinical Research Organization
2.6 Functional Service Provider (FSP) Clinical Research Organization Market Competitive Analysis
2.6.1 Functional Service Provider (FSP) Clinical Research Organization Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Functional Service Provider (FSP) Clinical Research Organization Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Service Provider (FSP) Clinical Research Organization as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Preclinical CRO
3.1.2 Clinical CRO
3.2 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type
3.2.1 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value, by Type (2019-2030)
3.2.3 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Small Medium Enterprise
4.1.2 Large Enterprise
4.2 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application
4.2.1 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value, by Application (2019-2030)
4.2.3 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region
5.1.1 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region (2019-2024)
5.1.3 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region (2025-2030)
5.1.4 Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
5.2.2 North America Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
5.3.2 Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
5.4.2 Asia Pacific Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
5.5.2 South America Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
5.6.2 Middle East & Africa Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Functional Service Provider (FSP) Clinical Research Organization Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Functional Service Provider (FSP) Clinical Research Organization Sales Value
6.3 United States
6.3.1 United States Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
6.3.2 United States Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
6.4.2 Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
6.5.2 China Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
6.5.3 China Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
6.6.2 Japan Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
6.7.2 South Korea Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
6.8.2 Southeast Asia Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019-2030
6.9.2 India Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
6.9.3 India Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 IQVIA
7.1.1 IQVIA Profile
7.1.2 IQVIA Main Business
7.1.3 IQVIA Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.1.4 IQVIA Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.1.5 IQVIA Recent Developments
7.2 Labcorp
7.2.1 Labcorp Profile
7.2.2 Labcorp Main Business
7.2.3 Labcorp Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.2.4 Labcorp Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.2.5 Labcorp Recent Developments
7.3 Syneos Health
7.3.1 Syneos Health Profile
7.3.2 Syneos Health Main Business
7.3.3 Syneos Health Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.3.4 Syneos Health Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.3.5 PPD Recent Developments
7.4 PPD
7.4.1 PPD Profile
7.4.2 PPD Main Business
7.4.3 PPD Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.4.4 PPD Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.4.5 PPD Recent Developments
7.5 ICON
7.5.1 ICON Profile
7.5.2 ICON Main Business
7.5.3 ICON Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.5.4 ICON Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.5.5 ICON Recent Developments
7.6 PRA
7.6.1 PRA Profile
7.6.2 PRA Main Business
7.6.3 PRA Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.6.4 PRA Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.6.5 PRA Recent Developments
7.7 Parexel
7.7.1 Parexel Profile
7.7.2 Parexel Main Business
7.7.3 Parexel Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.7.4 Parexel Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.7.5 Parexel Recent Developments
7.8 Medpace
7.8.1 Medpace Profile
7.8.2 Medpace Main Business
7.8.3 Medpace Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.8.4 Medpace Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.8.5 Medpace Recent Developments
7.9 Wuxi Apptec
7.9.1 Wuxi Apptec Profile
7.9.2 Wuxi Apptec Main Business
7.9.3 Wuxi Apptec Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.9.4 Wuxi Apptec Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.9.5 Wuxi Apptec Recent Developments
7.10 EPS International
7.10.1 EPS International Profile
7.10.2 EPS International Main Business
7.10.3 EPS International Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
7.10.4 EPS International Functional Service Provider (FSP) Clinical Research Organization Revenue (US$ Million) & (2019-2024)
7.10.5 EPS International Recent Developments
8 Industry Chain Analysis
8.1 Functional Service Provider (FSP) Clinical Research Organization Industrial Chain
8.2 Functional Service Provider (FSP) Clinical Research Organization Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Functional Service Provider (FSP) Clinical Research Organization Sales Model
8.5.2 Sales Channel
8.5.3 Functional Service Provider (FSP) Clinical Research Organization Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Functional Service Provider (FSP) Clinical Research Organization Market Trends
    Table 2. Functional Service Provider (FSP) Clinical Research Organization Market Drivers & Opportunity
    Table 3. Functional Service Provider (FSP) Clinical Research Organization Market Challenges
    Table 4. Functional Service Provider (FSP) Clinical Research Organization Market Restraints
    Table 5. Global Functional Service Provider (FSP) Clinical Research Organization Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Functional Service Provider (FSP) Clinical Research Organization Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Functional Service Provider (FSP) Clinical Research Organization Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Functional Service Provider (FSP) Clinical Research Organization Product Type
    Table 9. Key Companies Time to Begin Mass Production of Functional Service Provider (FSP) Clinical Research Organization
    Table 10. Global Functional Service Provider (FSP) Clinical Research Organization Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Service Provider (FSP) Clinical Research Organization as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Functional Service Provider (FSP) Clinical Research Organization Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Functional Service Provider (FSP) Clinical Research Organization Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Functional Service Provider (FSP) Clinical Research Organization Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Functional Service Provider (FSP) Clinical Research Organization Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region (2019-2024) & (%)
    Table 27. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Functional Service Provider (FSP) Clinical Research Organization Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2025-2030) & (US$ Million)
    Table 31. IQVIA Basic Information List
    Table 32. IQVIA Description and Business Overview
    Table 33. IQVIA Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of IQVIA (2019-2024)
    Table 35. IQVIA Recent Developments
    Table 36. Labcorp Basic Information List
    Table 37. Labcorp Description and Business Overview
    Table 38. Labcorp Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of Labcorp (2019-2024)
    Table 40. Labcorp Recent Developments
    Table 41. Syneos Health Basic Information List
    Table 42. Syneos Health Description and Business Overview
    Table 43. Syneos Health Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of Syneos Health (2019-2024)
    Table 45. Syneos Health Recent Developments
    Table 46. PPD Basic Information List
    Table 47. PPD Description and Business Overview
    Table 48. PPD Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of PPD (2019-2024)
    Table 50. PPD Recent Developments
    Table 51. ICON Basic Information List
    Table 52. ICON Description and Business Overview
    Table 53. ICON Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of ICON (2019-2024)
    Table 55. ICON Recent Developments
    Table 56. PRA Basic Information List
    Table 57. PRA Description and Business Overview
    Table 58. PRA Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of PRA (2019-2024)
    Table 60. PRA Recent Developments
    Table 61. Parexel Basic Information List
    Table 62. Parexel Description and Business Overview
    Table 63. Parexel Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of Parexel (2019-2024)
    Table 65. Parexel Recent Developments
    Table 66. Medpace Basic Information List
    Table 67. Medpace Description and Business Overview
    Table 68. Medpace Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of Medpace (2019-2024)
    Table 70. Medpace Recent Developments
    Table 71. Wuxi Apptec Basic Information List
    Table 72. Wuxi Apptec Description and Business Overview
    Table 73. Wuxi Apptec Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of Wuxi Apptec (2019-2024)
    Table 75. Wuxi Apptec Recent Developments
    Table 76. EPS International Basic Information List
    Table 77. EPS International Description and Business Overview
    Table 78. EPS International Functional Service Provider (FSP) Clinical Research Organization Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Functional Service Provider (FSP) Clinical Research Organization Business of EPS International (2019-2024)
    Table 80. EPS International Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Functional Service Provider (FSP) Clinical Research Organization Downstream Customers
    Table 84. Functional Service Provider (FSP) Clinical Research Organization Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Functional Service Provider (FSP) Clinical Research Organization Product Picture
    Figure 2. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value (2019-2030) & (US$ Million)
    Figure 4. Functional Service Provider (FSP) Clinical Research Organization Report Years Considered
    Figure 5. Global Functional Service Provider (FSP) Clinical Research Organization Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Functional Service Provider (FSP) Clinical Research Organization Revenue in 2023
    Figure 7. Functional Service Provider (FSP) Clinical Research Organization Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Preclinical CRO Picture
    Figure 9. Clinical CRO Picture
    Figure 10. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Small Medium Enterprise
    Figure 13. Product Picture of Large Enterprise
    Figure 14. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Functional Service Provider (FSP) Clinical Research Organization Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Functional Service Provider (FSP) Clinical Research Organization Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Functional Service Provider (FSP) Clinical Research Organization Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Functional Service Provider (FSP) Clinical Research Organization Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Functional Service Provider (FSP) Clinical Research Organization Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Functional Service Provider (FSP) Clinical Research Organization Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Functional Service Provider (FSP) Clinical Research Organization Sales Value (%), (2019-2030)
    Figure 27. United States Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Functional Service Provider (FSP) Clinical Research Organization Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Functional Service Provider (FSP) Clinical Research Organization Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Functional Service Provider (FSP) Clinical Research Organization Sales Value by Application (%), 2023 VS 2030
    Figure 48. Functional Service Provider (FSP) Clinical Research Organization Industrial Chain
    Figure 49. Functional Service Provider (FSP) Clinical Research Organization Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS